KHA Releases One-Pager Supporting SB 27

Share

Protect Private Money Providing Patient Access

The 340B drug discount program is a privately funded, federally administered system. The program allows non-profit, safety-net hospitals to purchase outpatient medications from pharmaceutical manufacturers at the same price the manufacturers charge their best customers – NOT for free.

Pharmaceutical manufacturers, which continue to have record profits, agreed to fund the 340B program in order to be a part of Obamacare. Now they want to back out of that commitment. Their refusal to ship prescription drugs comes at the expense of the poorest and most vulnerable patients being served by 340B hospitals.

The savings from the program help Kentucky hospitals to maintain access to care and make it possible for hospitals to offer additional services to their patients.

Latest News

Uncategorized
July 25, 2024
The KHA Quality Team congratulates colleagues from member hospitals for being awarded KHA scholarships to attend the 18th Annual PESI Rehab Orthopedic and Neuro Rehab Summit.
News
July 24, 2024
KHA just launched an interactive webpage with details on hospital workforce projects across the Commonwealth.
News
July 22, 2024
KHA’s workforce study was recently cited in an article on Eastern Kentucky University (EKU) addressing the medical provider shortage in Kentucky.